Gastrointestinal tumours, non-colorectal
Invited discussant abstracts 620PD, 621PD and 622PD
Date
08 Oct 2016Session
Gastrointestinal tumours, non-colorectalPresenters
Eduardo Diaz RubioAuthors
E. Diaz RubioAuthor affiliations
- Oncologia Medica, Hospital Clinico Universitario San Carlos, 28040 - Madrid/ES
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
2637 - Randomized, open-label, phase III study comparing irinotecan plus S-1 with S-1 alone in patients with advanced esophageal squamous cell carcinoma after failure of prior platinum- or taxane-based chemotherapy: Results of an interim analysis
Presenter: Jing Huang
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
2321 - Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (LAPC): Final analysis of JCOG1106
Presenter: Tatsuya Ioka
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
1861 - Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Prognosis, efficacy, and safety by liver disease etiology
Presenter: Takuji Okusaka
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
2268 - Prognostic factors in curative treatment of gallbladder cancer - Data of 950 cases of “The German- Registry”
Presenter: Thorsten Goetze
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
2823 - Phase III study comparing intraperitoneal paclitaxel plus S-1/paclitaxel with S-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial
Presenter: Yoshiyuki Fujiwara
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
4066 - Molecular characteristics of hepatocellular carcinomas (HCC) from different age groups
Presenter: Celina Ang
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Invited discussant abstracts LBA26, LBA27 and 616PD
Presenter: Eric Van Cutsem
Session: Gastrointestinal tumours, non-colorectal
Resources:
Slides
Invited discussant abstracts 617PD, 618PD, 619PD and LBA28
Presenter: Florian Lordick
Session: Gastrointestinal tumours, non-colorectal
Resources:
Slides
3707 - Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
Presenter: Li-Tzong Chen
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
3822 - Efficacy, safety, and health-related quality of life (HRQoL) of regorafenib in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: Results of the international, double-blind phase 3 RESORCE trial
Presenter: Jordi Bruix
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.